Publications by authors named "David Seher"
Article Synopsis
- * Traditional NSAIDs can have side effects by disrupting the production of beneficial compounds, but new multi-target inhibitors like diflapolin offer potential improved efficacy and safety despite challenges with solubility and bioavailability.
- * Researchers have designed new derivatives using thiazolopyridines to enhance solubility and target specific enzymes; one such derivative effectively inhibits lipid mediators while also reducing thromboxane production, suggesting a promising strategy for broadening treatment applications.
